Wegovy pills: what the oral semaglutide tablet approval means for you

What the MHRA approval data tells us about Wegovy pills

The pivotal evidence comes from OASIS 4, a phase-3 randomised trial that followed 307 adults living with obesity or overweight alongside at least one weight-related condition, without type 2 diabetes, for 64 weeks. Participants who received oral semaglutide 25 mg lost an average of approximately 13.6% of their body weight compared with around 2.4% in the placebo group. Among those who adhered fully to the treatment, the average reduction climbed to roughly 16.6%, close to 17%. That fully-adherent figure is worth holding onto, but it has an important caveat: it applies only to the subset who stayed consistently on treatment, not to every participant who enrolled. The more conservative 13.6% is the headline average across the whole group.

The most common side effects reported in the trial were gastrointestinal: nausea, vomiting, diarrhoea and constipation. They occurred in about 74% of participants taking oral semaglutide, compared with 42% on placebo, and were generally mild to moderate, typically most noticeable when starting or stepping up the dose. That pattern mirrors what is seen with GLP-1 medicines broadly. The MHRA's recent communications on semaglutide approvals also reflect the regulator's growing confidence in this class of medicine beyond straightforward weight management.

The tablet co-formulates semaglutide with an absorption enhancer called SNAC, which protects the molecule from stomach acid long enough to allow meaningful absorption through the gastric lining. Oral bioavailability of semaglutide is still lower than with injections, which is why the tablet dose (25 mg at maintenance) is considerably higher than the 2.4 mg weekly injection, even though the two products produce broadly comparable effects on appetite and body weight over time. If you want to understand more about how Wegovy weight loss pills compare with the injection in practical terms, that page sets out the key differences clearly.

Taking a Wegovy pill correctly: the morning routine that matters

How the tablet is taken affects how much of the active ingredient reaches the bloodstream. The instructions reflect the absorption chemistry: first thing in the morning, on a completely empty stomach, swallowed whole with a small amount of plain water, up to about 120 ml. After taking it, you wait at least 30 minutes before eating, drinking anything other than plain water, or taking any other oral medicine. Coffee, tea and juice all count as drinks for this purpose. Missing that window is one of the most common practical mistakes.

A quick checking habit worth building into day one: before swallowing the tablet, glance at the clock on your phone and set a 30-minute reminder. It takes under a minute and removes the guesswork entirely on busy mornings.

Storage is straightforward compared with the weekly injection. No refrigerator is required; the tablets keep at room temperature, which makes them considerably easier to manage when travelling or when fridge space is shared. The exact storage conditions are set out in the Patient Information Leaflet, and those instructions take precedence over anything summarised here. For a full overview of what oral semaglutide involves, the Wegovy pill treatment page covers the practical and clinical picture in detail.

Who Wegovy pills in the UK are licensed for

The MHRA licensed Wegovy tablets for adults with a BMI of 30 or above, or a BMI between 27 and 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Treatment is intended to complement a reduced-calorie diet and increased physical activity, not replace them.

Rybelsus (also oral semaglutide, but at 3 mg, 7 mg and 14 mg doses) is licensed only for type 2 diabetes. Those strengths are not steps on the Wegovy weight-loss ladder and should not be confused with it. If you have come across references to oral semaglutide in a diabetes context, the semaglutide pills guide clarifies the distinction clearly.

Pregnancy, breastfeeding and actively trying to conceive are all situations where Wegovy tablets are not recommended. The medicine is not licensed for anyone under 18. People with a personal or family history of medullary thyroid carcinoma, or a condition called MEN2, should not take semaglutide, and anyone with a history of pancreatitis needs to discuss their situation with a prescriber before starting. BMI thresholds under UK guidance are also 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, which brings more people into the licensed range.

NHS availability, private access, and what to weigh up

As of summer 2026, Wegovy tablets are not available on the NHS. NICE would need to complete a formal appraisal before NHS commissioning could follow, and that process takes time. For context, NICE's appraisal of the Wegovy injection (TA875) restricts NHS access to specialist weight management services with strict criteria; any equivalent route for the tablet would likely involve a similar process.

For now, the only route to Wegovy pills in the UK is a private prescription following a clinical assessment. That assessment matters: it is what confirms the medicine is appropriate for your specific health picture and excludes contraindications before any treatment starts. If you are curious about what that process involves and how pricing works, the cost of Wegovy pills page sets out what a private prescription typically includes.

Thinking through which weight-loss medicine suits your circumstances (whether that is the Wegovy tablet, the weekly injection, or another option entirely) is ultimately a clinical question, and if you are still asking are there Wegovy pills available in the UK right now, that page gives a direct and up-to-date answer. The weight-loss treatment overview sets out what is currently available, and a consultation with a prescriber is the right way to work through the specifics. When you are ready, check your eligibility with our clinical team to see whether Wegovy pills could be appropriate for you, and you can also read more about Wegovy as a pill if you want a focused look at what taking the tablet form of this medicine actually involves day to day.